FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Börse Stuttgart 01:50:54 06/06/2024 pm IST | ||
| 11.58 EUR | -4.53% |
|
| Current month | +98.63% | ||
| 1 month | +29.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 06/24/06 | 11.58 | -4.53% |
| 05/24/05 | 12.13 | +17.77% |
| 04/24/04 | 10.3 | +10.16% |
| 03/24/03 | 9.35 | +60.38% |
| 31/24/31 | 5.83 | +31.31% |
Delayed Quote Börse Stuttgart
Last update June 06, 2024 at 01:50 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD462W |
| ISIN | DE000HD462W5 |
| Date issued | 27/03/2024 |
| Strike | 209.1 $ |
| Maturity | Unlimited |
| Parity | 2.72 : 1 |
| Emission price | 10.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.02 € |
|---|---|
| Lowest since issue | 2.49 € |
| Spread | 0.12 € |
| Spread % | 1.30% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
232
USD
Average target price
284.6
USD
Spread / Average Target
+22.70%
- Stock Market
- Certificates
- Certificat
